446 related articles for article (PubMed ID: 21690428)
1. Inhaler device selection: special considerations in elderly patients with chronic obstructive pulmonary disease.
Barrons R; Pegram A; Borries A
Am J Health Syst Pharm; 2011 Jul; 68(13):1221-32. PubMed ID: 21690428
[TBL] [Abstract][Full Text] [Related]
2. [Chinese expert consensus on standardized inhaler device application in stable chronic airway diseases (2023)].
Inhalation Therapy and Respiratory Rehabilitation Group, Respiratory Equipment Committee of China Association of Medical Equipment
Zhonghua Jie He He Hu Xi Za Zhi; 2023 Nov; 46(11):1055-1067. PubMed ID: 37914418
[TBL] [Abstract][Full Text] [Related]
3. Optimizing drug delivery in COPD: The role of inhaler devices.
Rogliani P; Calzetta L; Coppola A; Cavalli F; Ora J; Puxeddu E; Matera MG; Cazzola M
Respir Med; 2017 Mar; 124():6-14. PubMed ID: 28284323
[TBL] [Abstract][Full Text] [Related]
4. The importance of inhaler devices: the choice of inhaler device may lead to suboptimal adherence in COPD patients.
Darbà J; Ramírez G; Sicras A; Francoli P; Torvinen S; Sánchez-de la Rosa R
Int J Chron Obstruct Pulmon Dis; 2015; 10():2335-45. PubMed ID: 26604733
[TBL] [Abstract][Full Text] [Related]
5. Practical problems with aerosol therapy in COPD.
Rau JL
Respir Care; 2006 Feb; 51(2):158-72. PubMed ID: 16441960
[TBL] [Abstract][Full Text] [Related]
6. Tiotropium administered by a pressurized metered dose inhaler (pMDI) and spacer produces a similar bronchodilator response as that administered by a Rotahaler in adult subjects with stable moderate-to-severe COPD.
Brashier B; Dhembare P; Jantikar A; Mahadik P; Gokhale P; Gogtay JA; Salvi SS
Respir Med; 2007 Dec; 101(12):2464-71. PubMed ID: 17719763
[TBL] [Abstract][Full Text] [Related]
7. Comparative Study of Inhaler Device Handling Technique and Risk Factors for Critical Inhaler Errors in Korean COPD Patients.
Jang JG; Chung JH; Shin KC; Jin HJ; Lee KH; Ahn JH
Int J Chron Obstruct Pulmon Dis; 2021; 16():1051-1059. PubMed ID: 33907392
[TBL] [Abstract][Full Text] [Related]
8. Considerations for Optimal Inhaler Device Selection in Chronic Obstructive Pulmonary Disease.
Dhand R; Cavanaugh T; Skolnik N
Cleve Clin J Med; 2018 Feb; 85(2 Suppl 1):S19-S27. PubMed ID: 29494329
[No Abstract] [Full Text] [Related]
9. Factors associated with appropriate inhaler use in patients with COPD - lessons from the REAL survey.
Price D; Keininger DL; Viswanad B; Gasser M; Walda S; Gutzwiller FS
Int J Chron Obstruct Pulmon Dis; 2018; 13():695-702. PubMed ID: 29520137
[TBL] [Abstract][Full Text] [Related]
10. Maintenance inhaler preference, attribute importance, and satisfaction in prescribing physicians and patients with asthma, COPD, or asthma-COPD overlap syndrome consulting for routine care.
Ding B; Small M; Scheffel G; Holmgren U
Int J Chron Obstruct Pulmon Dis; 2018; 13():927-936. PubMed ID: 29588581
[TBL] [Abstract][Full Text] [Related]
11. Demystifying Dry Powder Inhaler Resistance with Relevance to Optimal Patient Care.
Capstick TGD; Gudimetla S; Harris DS; Malone R; Usmani OS
Clin Drug Investig; 2024 Feb; 44(2):109-114. PubMed ID: 38198116
[TBL] [Abstract][Full Text] [Related]
12. Device selection and outcomes of aerosol therapy: Evidence-based guidelines: American College of Chest Physicians/American College of Asthma, Allergy, and Immunology.
Dolovich MB; Ahrens RC; Hess DR; Anderson P; Dhand R; Rau JL; Smaldone GC; Guyatt G; ;
Chest; 2005 Jan; 127(1):335-71. PubMed ID: 15654001
[TBL] [Abstract][Full Text] [Related]
13. Optimising Inhaled Pharmacotherapy for Elderly Patients with Chronic Obstructive Pulmonary Disease: The Importance of Delivery Devices.
Lavorini F; Mannini C; Chellini E; Fontana GA
Drugs Aging; 2016 Jul; 33(7):461-73. PubMed ID: 27216613
[TBL] [Abstract][Full Text] [Related]
14. The role of nebulized therapy in the management of COPD: evidence and recommendations.
Dhand R; Dolovich M; Chipps B; Myers TR; Restrepo R; Farrar JR
COPD; 2012 Feb; 9(1):58-72. PubMed ID: 22292598
[TBL] [Abstract][Full Text] [Related]
15. Optimising inhaler technique in chronic obstructive pulmonary disease: a complex issue.
Riley J; Krüger P
Br J Nurs; 2017 Apr; 26(7):391-397. PubMed ID: 28410043
[TBL] [Abstract][Full Text] [Related]
16. [Persistence to treatment by type of inhaler device in patients with asthma and chronic obstructive pulmonary disease].
Sicras A; Ferrer V; Collar JM; Navarro R; Sáez M
Semergen; 2017; 43(5):375-386. PubMed ID: 27425817
[TBL] [Abstract][Full Text] [Related]
17. Inhaler devices for patients with COPD.
Fink JB; Colice GL; Hodder R
COPD; 2013 Aug; 10(4):523-35. PubMed ID: 23537191
[TBL] [Abstract][Full Text] [Related]
18. A Randomized, Crossover Trial Evaluating Patient Handling, Preference, and Ease of Use of the Fluticasone Propionate/Formoterol Breath-Triggered Inhaler.
Bell D; Mansfield L; Lomax M
J Aerosol Med Pulm Drug Deliv; 2017 Dec; 30(6):425-434. PubMed ID: 28683212
[TBL] [Abstract][Full Text] [Related]
19. Patient preferences for inhaler devices in chronic obstructive pulmonary disease: experience with Respimat Soft Mist inhaler.
Hodder R; Price D
Int J Chron Obstruct Pulmon Dis; 2009; 4():381-90. PubMed ID: 19888356
[TBL] [Abstract][Full Text] [Related]
20. Patient preferences for dry powder inhaler attributes in asthma and chronic obstructive pulmonary disease in France: a discrete choice experiment.
Hawken N; Torvinen S; Neine ME; Amri I; Toumi M; Aballéa S; Plich A; Roche N
BMC Pulm Med; 2017 Jul; 17(1):99. PubMed ID: 28683805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
